Pharmaxis Ltd. (PXS.AX)
-ASX 0.23 
0.05(27.78%) 24 May 16:10
| Prev Close: | 0.18 |
|---|
| Open: | 0.20 |
|---|
| Bid: | 0.23 |
|---|
| Ask: | 0.23 |
|---|
| 1y Target Est: | 0.35 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.20 - 0.24 |
|---|
| 52wk Range: | 0.12 - 1.42 |
|---|
| Volume: | 10,856,434 |
|---|
| Avg Vol (3m): | 2,693,810 |
|---|
| Market Cap: | 71.07M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in AUD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 21.00 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | -0.13 |
|---|
| Quarterly EPS Est
(Mar-13)
: | N/A |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 0.14 |
|---|
Business Summary
Pharmaxis Ltd, a pharmaceutical company, engages in the research, development, and commercialization of human healthcare products for the treatment and management of respiratory diseases in the United States, Europe, Australia, and southeast Asia.
View More